About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• HIV prevalence may decline because the most vulnerable are infected and die first
• Lack of perceived need for HIV treatment associated with poor adherence
• TB doesn't always increase HIV viral load
• New 75mg darunavir tablet approved by FDA for use by HIV-positive children
• Thyroid checks recommended for people with HIV
• Knighthood for head of UK HIV charity
• Gay men often not accessing PEP despite risk of HIV exposure
• Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
• Internalised homophobia leads to sexual risk taking by HIV-positive gay men
• Most gay men willing to consider PrEP for possible HIV exposure